Cancer clinical trials in Geneva
90 open trials with at least one site in Geneva, according to ClinicalTrials.gov, updated on October 28, 2026.
These results are indicative and do not replace medical advice — discuss them with your doctor.
Open trials
- Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50%
NCT07020065RecruitingPhase 2
- Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
NCT07158489RecruitingPhase 2
- Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)
NCT07365423RecruitingPhase 2
- Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)
NCT06780111RecruitingPhase 1 · Phase 2
- MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.
NCT07574047RecruitingPhase 2
- Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion in Chimeric Antigen Receptor T-cell Immunotherapy (CAR-T): a Randomized Trial.
NCT07593482RecruitingPhase 2
- Comprehensive Palliative Care After Stem Cell Transplantation: a Feasability Study
NCT07895693Recruiting
- A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
NCT06090539RecruitingPhase 1 · Phase 2
- The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated Lymphedema
NCT05890677Recruiting
- An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
NCT05939414RecruitingPhase 3
- LUCINAE Registry: Thoracic Cancers During Pregnancy
NCT07699861Recruiting
- A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
NCT06428409RecruitingPhase 1 · Phase 2
- AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
NCT07611110RecruitingPhase 3
- A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT06925737RecruitingPhase 3
- Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07214779RecruitingPhase 3
- Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
NCT07140172Recruiting
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
NCT06393374RecruitingPhase 3
- A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
NCT07318558RecruitingPhase 3
- Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT06401980RecruitingPhase 2
- Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma
NCT06563362RecruitingPhase 2
- A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
NCT07213804RecruitingPhase 3
- Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
NCT07223814RecruitingPhase 3
- A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
NCT07522073RecruitingPhase 3
- A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
NCT05319730RecruitingPhase 1 · Phase 2
- Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
NCT06469944RecruitingPhase 1 · Phase 2
- A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
NCT06793215RecruitingPhase 3
- A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06760819RecruitingPhase 2
- FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990RecruitingPhase 2 · Phase 3
- A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)
NCT07405151RecruitingPhase 1 · Phase 2
- Tractography-Guided Nerve-Sparing in Prostate Cancer
NCT07847385Recruiting
- A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
NCT07365241RecruitingPhase 3
- A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2
NCT07203053RecruitingPhase 2
- SPECTRA: Intraoperative Hyperspectral Imaging for Prostate Cancer
NCT07826858Recruiting
- A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
NCT06492616RecruitingPhase 3
- A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
NCT07023627RecruitingPhase 2
- Safety and Early Signs of Efficacy of IL12-L19L19.
NCT04471987RecruitingPhase 1
- Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
NCT01949129RecruitingPhase 2 · Phase 3
- Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)
NCT06445972RecruitingPhase 1 · Phase 2
- Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
NCT06652438RecruitingPhase 3
- DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732Recruiting
- ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer
NCT06801899Recruiting
- Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
NCT06562192RecruitingPhase 1
- FAPI PET Imaging - An Exploratory Study
NCT07705074Not yet recruitingPhase 1 · Phase 2
- Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma
NCT05700149Recruiting
- Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea
NCT07173348Recruiting
- Cardiac Dysfunction in Childhood Cancer Survivors
NCT03790943Recruiting
- Male Fertility Preservation Using Cryopreservation of Testicular Tissue Before Highly Gonadotoxic Cancer Treatment
NCT03180918Recruiting
- A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
NCT06256588RecruitingPhase 3
- Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer
NCT06274879RecruitingPhase 2
- A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
NCT06567782RecruitingPhase 2
- Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland
NCT03124212Recruiting
- Ablative SBRT in Elderly BC Patients
NCT06523894Recruiting
- Early Pulmonary Dysfunction in Childhood Cancer Patients
NCT05427136Recruiting
- International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
NCT04043494RecruitingPhase 3
- The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters
NCT07173127Recruiting
- Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients
NCT06114108Recruiting
- Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery - a Randomized Controlled Study
NCT07479407Not yet recruiting
- Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection
NCT07461675Not yet recruitingPhase 3
- Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma
NCT07302919RecruitingPhase 2 · Phase 3
- Home-Based Physiotherapy in Oncology
NCT07440433Not yet recruiting
- Time-Restricted Eating in Menopause and HOrmone-sensitive Breast Cancers (TREMHO)
NCT06855784Recruiting
- Breathlessness Patterns in Patients With Cancer, COPD and Heart Failure: an fMRI Feasibility Study
NCT07319039Recruiting
- Breast Cancer-Related Approach for Increasing Cervical Cancer Screening
NCT07171658Recruiting
- Phase II Study of Radiotherapy Followed by Durvalumab and Ceralasertib in Stage III NSCLC Patients With Thoracic Relapses +/- Oligometastases After PACIFIC Regimen
NCT06680050RecruitingPhase 2
- HOPE Against Cancer Recurrence in HCC
NCT06717919RecruitingPhase 4
- PTX3-targeted Antifungal Prophylaxis
NCT03828773Recruiting
- The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)
NCT05726786RecruitingPhase 3
- MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
NCT04111978RecruitingPhase 3
- The Swiss Childhood Cancer Survivor Study - Follow-up (SCCSS-FollowUp)
NCT04732273Recruiting
- Protoporphyrin Imaging in Multispectral Evaluation of Resections
NCT07021573Not yet recruiting
- Impact of a mHealth Supportive Tool on Cardiopulmonary Resuscitation' Situational Awareness
NCT04464603Not yet recruiting
- Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)
NCT06154785Recruiting
- EMPATHY NSCLC: European Registry for Plasma-Based Molecular Profiling in Advanced NSCLC Patients
NCT07096258Recruiting
- SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
NCT05192980Recruiting
- Extended vs. No Pelvic Lymph Node Dissection During Radical Prostatectomy. DISSECTION 2.0.
NCT06776172Recruiting
- Biograph Vision 600 Versus Biograph Vision.X PET/CT
NCT07006155Recruiting
- Improvement in Breast Skin Sensibility After Breast Reconstruction: a Comparison of 3 Surgical Techniques
NCT06930378Recruiting
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
NCT03643276RecruitingPhase 3
- E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
NCT03818503Recruiting
- Swiss Severe Asthma Register
NCT03984253Recruiting
- EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases
NCT05688241Not yet recruitingPhase 1 · Phase 2
- Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC
NCT05066412RecruitingPhase 1
- Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
NCT05641441Recruiting
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
NCT05017142Recruiting
- Microbiota and Pancreatic Cancer Cachexia
NCT05606523Recruiting
- Patient-derived Organoids of Lung Cancer to Test Drug Response
NCT03979170Recruiting
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
NCT04625907RecruitingPhase 1 · Phase 2
- Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
NCT04109755RecruitingPhase 2
- Genetic Risks for Childhood Cancer Complications in Switzerland
NCT04702321Recruiting
- ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer
NCT03294889RecruitingPhase 1 · Phase 2